Skip to content

Effect of Large Language Model in Assisting Discharge Summary Notes Writing for Hospitalized Patients

Effect of Large Language Model in Assisting Discharge Summary Notes Writing for Hospitalized Patients: A Pilot Pragmatic Randomized Controlled Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06263855
Enrollment
0
Registered
2024-02-16
Start date
2026-01-01
Completion date
2026-10-01
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large Language Model

Brief summary

This pilot study aims to assess the feasibility of carrying out a full-scale pragmatic, cluster-randomized controlled trial which will investigate whether discharge summary writing assisted by a large language model (LLM), called CURE (Checker for Unvalidated Response Errors), improves care delivery without adversely impacting patient outcomes.

Interventions

OTHERCURE

A large language model (LLM) to help clinicians prepare discharge summaries for hospitalized patients.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

PATIENTS Inclusion Criteria: * Adult patients admitted to one of three participating cardiology services at Mayo Clinic in Rochester, MN

Exclusion criteria

* Minor patients (\<18) * Patients admitted to a hospital service where CURE is not implemented CLINICIANS Inclusion Criteria: * Clinicians who provide care to randomized patients included in this pilot

Design outcomes

Primary

MeasureTime frameDescription
Rate of patient accrualThree monthsThe first feasibility outcome will be the rate of patient accrual. An accrual of one patient per day will be considered acceptable, i.e., 91 patients discharged from a 91-day period who are appropriately randomized and can be included in the analyses.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORXiaoxi Yao

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026